Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

FB23-2

Inquiry
Cat. No.: OB0125LY-087
Size: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 500 mg
CAS No.: 2243736-45-8
Compound CID: 138454779
FB23-2

Specification

Description: FB23-2 is a selective inhibitor that inhibits mRNA N6-methyladenosine (m6A) demethylase FTO.
Formula Weight: 392.24
Stability: 3 years in powder form.
Applications: FB23-2 is mainly used in biomedical research, especially in cancer research, to explore its potential as an anti-tumor drug.
Storage: Storage at -20°C.
Formula: C18H15Cl2N3O3
Appearance: Solid
Purity: 98%
Identity: Confirmed by NMR and HPLC.
Targets&IC50: FTO: 2.6 μM (IC50)
Relative Density: 1.428 g/cm3

Library Information

Plate Number: AOCL-31
Plate Location: e9
Empty Location: a1-h1; a12-h12
Formulation: 10mM DMSO
Container: 96-well plate
Pathways: Apoptosis
Targets: Apoptosis
Receptors: Apoptosis; mRNA N6-methyladenosine (m6A) demethylase FTO
DMSO Max Solubility (mg/mL): 1 mg/mL
Inquiry

Copyright © Protheragen. All rights reserves.